Press Releases

13 June 2017 – NK Ingredients Pte Ltd Singapore site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the NK Ingredients Pte Ltd Singapore site has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the NK Ingredients Pte Ltd site in Singapore manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of lanolin, lanolin derivatives and cholesterol for pharmaceutical use.

Read more

08 June 2017 – Star-Tech & JRS Specialty Products Co., Ltd Chinese site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the Star-Tech & JRS Specialty Products Co., Ltd Chinese site has recently been awarded an EXCiPACT Certificate from BV China, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Star-Tech & JRS Specialty Products Co., Ltd site in Changsou District, Chongqing, China manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of Povidone, Crospovidone and Copovidone.

Read more

06 June 2017 – Asha Cellulose (I) Pvt. Ltd. site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the Asha Cellulose (I) Pvt. Ltd. site has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Asha Cellulose (I) Pvt. Ltd. site in Valsad, Gujarat, India manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture and supply of ethylcellulose and aqueous dispersion of ethylcellulose for use as pharmaceutical excipients.

Read more

30 May 2017 – Ashland Speciality Ingredients Belgium site receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that the Ashland Speciality Ingredients site in Doel, Belgium has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Ashland Speciality Ingredients (ASI) site in Doel, Belgium, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers the production of methylcellulose (MC), hydroxypropylmethylcellulose (HPMC) and methylhydroxyethylcellulose (MHEC) as pharmaceutical excipients.

Read more

23 May 2017 – Sigachi Industries Pvt. Ltd. Indian site receives EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that the Sigachi Industries Pvt. Ltd.’s site in Dahej, India has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Sigachi Industries Pvt. Ltd.’s site in Dahej, District Bharuch, Gujarat in India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers Manufacture and supply of cellulose based pharmaceutical excipients in the pharmaceutical industry.

Read more

16 May 2017 – Shanxi Guangsheng Medicinal Capsule Co., Ltd site receives EXCiPACT GMP Certification

EXCiPACT asbl is delighted to announce that the Shanxi Guangsheng Medicinal Capsule Co., Ltd’s Shanxi Province site has recently been awarded an EXCiPACT Certificate from BV China, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Shanxi Guangsheng Medicinal Capsule Co., Ltd site in Jinzhong City, Shanxi Province, China, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of Gelatin, Pullulan and HPMC printed and unprinted empty capsule for pharmaceutical use.

Read more

06 April 2017 – Croda Japan’s Shiga factory receives EXCiPACT GMP certification

EXCiPACT asbl is pleased to announce their very first Japanese certification.

The Croda Japan K.K. Shiga factory has just been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Croda Japan Shiga factory in Shiga-Ken, Japan manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of pharmaceutical excipients, (functional ester derivative, purified mineral oil, vegetable oil, wax, fatty acid and lanolin).

Read more

04 April 2017 – Both Croda Inc. manufacturing sites in the USA receive GMP certification

EXCiPACT asbl is delighted to announce that both Croda Inc. manufacturing sites in the USA have recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificates demonstrates that the Croda Inc. sites in Mill Hall, Pennsylvania and in New Castle, Delaware manufacture pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  The scope covers the manufacturing of alkyloxylates, esters and super refined oils and PEGs at Mill Hall and the manufacturing of alkyloxylates and esters at New Castle.

Read more

23 March 2017 – Chemische Fabrik Budenheim KG site in Budenheim receives EXCiPACT GMP/GDP certification

EXCiPACT asbl is delighted to announce that the Chemische Fabrik Budenheim KG site in Budenheim has recently been awarded an EXCiPACT GMP/GDP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Chemische Fabrik Budenheim KG site in Budenheim, Germany, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) Certification Standards.  Its scope covers manufacturing, testing, storage and distribution of sodium, magnesium and calcium phosphates for use as pharmaceutical excipients.

Read more

21 March 2017 – Sudeep Pharma’s Indian site in Switzerland receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that the Sudeep Pharma Private Ltd’s Vadodara site in India has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Sudeep Pharma Pvt. Ltd. site in Vadodara, Gujarat, India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers manufacture of different grades of Di basic calcium phosphate, Tri basic calcium phosphate and calcium carbonate for use as pharmaceutical excipients.

Read More

14 March 2017 – Carbagas Domdidier site in Switzerland receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that the Carbagas Domdidier site has recently been awarded an EXCiPACT Certificate from AJA, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Carbagas site in Domdidier, Switzerland, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing (filling) of pharmaceutical grade gases (nitrogen, oxygen, argon, carbon dioxide) in cylinders and bundles.

Read more

2017 EXCiPACT STANDARDS REVISION – STAKEHOLDER CONSULTATION OPENS

The EXCiPACT Board commissioned a project team to undertake a revision of the EXCiPACT standards to align them to ISO 9001:2015 and ISO/IEC 17021-1:2015 without change or enhancement of any individual requirements, other than to correct for errors in the original publication. The draft revision has been completed and is now available for public comment via a Review Template, mandatory for the submission of comments. Links to both documents are:

Read more

28 February 2017 – Chemfield Cellulose’ Indian Site receives EXCiPACT GMP certification

The Certificate demonstrates that the Chemfield Cellulose Private Ltd site in Nagpur, India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture and supply of different grades of Microcrystalline cellulose for use as excipients in pharmaceuticals.

Read more

21 February 2017 – Anhui Sunhere Pharmaceutical Excipients Chinese site receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that Anhui Sunhere Pharmaceutical Excipients Co. Ltd in Huainan, China has recently been awarded an EXCiPACT Certificate from BV China, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Anhui Sunhere Pharmaceutical Excipients Co. Ltd site in Huainan, Anhere, China, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers the manufacture of magnesium stearate, microcrystalline cellulose and low-substituted hydroxypropyl cellulose.

Read more

09 February 2017 – Ashland Specialties France site in Alizay receives EXCiPACT certficate

EXCiPACT asbl is delighted to announce that Ashland Specialties France has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Ashland Specialties France site in Alizay, France, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers manufacture of Carmellose Sodium / Sodium Carboxymethylcellulose in bags for use as excipient in the pharmaceutical industry.

Read more

07 February 2017 – KLK Emmerich site in Düsseldorf receives EXCiPACT certificate

EXCiPACT asbl is delighted to announce that KLK Emmerich GmbH has recently been awarded an EXCiPACT Certificate from DQS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that KLK Emmerich GmbH’s site in Düsseldorf, Germany, manufactures and distributes pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Certification Standards. Its scope covers the manufacturing and distribution of Glycerine Edenor® G86 PH and  Edenor®
G 99,8 PH including filling of tank trucks, drums, IBC, storage and dispatch. of pharmaceutical excipients.

Read more

10 January 2017 – VWR’S Ohio sites receive EXCiPACT GMP & GDP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that two VWR sites in Ohio, USA have each recently been awarded an EXCiPACT GMP & GDP Certificate from blue inspection body (bmb), one of EXCIPACT’s internationally-recognised Certification Bodies.

Separate bmb certificates demonstrate that the AMRESCO, LLC site in Solon, OH and the VWR Chemicals, LLC site in Aurora, OH – both owned by VWR International, LLC of Radnor, PA – operate their facilities according to the EXCiPACT Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Certification Standards. The scope at both sites covers sourcing, testing, packaging, storage, release and distribution of products for pharmaceutical excipient use; salts, carbohydrates, denaturants and buffers.

Read more

25 October 2016 – Ashland Industries Nederland’s Zwijndrecht site receives EXCiPACT certificate

EXCiPACT asbl is delighted to announce that Ashland Industries Nederland’s Zwijndrecht site has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Ashland Industries Nederland’s Zwijndrecht site in The Netherlands, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers the manufacturing of Hydroxy Ethyl Cellulose (Natrosol Pharm type) as a pharmaceutical excipient.

Read more

6 September 2016 – Air Liquide Benelux Industries Charleroi site receives EXCiPACT certificate

EXCiPACT asbl is delighted to announce that Air Liquide Benelux Industries’ Marchienne-au-Pont Charleroi site has recently been awarded an EXCiPACT GMP Certificate from DQS GmbH, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Air Liquide Benelux Industries site in Marchienne-au-Pont, Charleroi, Belgium, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers the production, purification, storage, loading and distribution of liquid nitrogen and liquid oxygen under the brand name Phargalis.

Read more

30 August 2016 – IPEC Association (China) Limited becomes a member of EXCiPACT asbl

The Board of EXCiPACT asbl is pleased to announce that the IPEC Association (China) Limited has recently become the fifth member of EXCiPACT asbl – the independent, voluntary 3rd party GMP/GDP certification program for manufacturers and distributors of pharmaceutical excipients – joining the four founding members – IPEC Europe, IPEC Americas, FECC, and PQG (UK).

Read more

23 August 2016 – Armor Protéines S.A.S. – Armor Pharma™ French site receives EXCiPACT certificate

EXCiPACT asbl is delighted to announce that the Armor Protéines S.A.S. – Armor Pharmasite has recently been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Armor Protéines S.A.S. – Armor Pharma™ site in Loudéac, France, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing, testing and storage of monohydrate lactose used as pharmaceutical excipient.

Read more

2 August 2016 – ACG Associated Capsules receives EXCiPACT certificate

EXCiPACT is pleased to announce that ACG Associated Capsules has recently been awarded an EXCiPACT Certificate from SGS, one of EXCiPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that ACG Associated Capsules site in Thanes, Maharashtra, India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers manufacturing of Hard Gelatin Capsule Shells IP, Hard Gelatin Capsule Shells and Cellulose Shells for pharmaceutical use.

Read more

28 July 2016 – Nanjing Duoyuan Biochemistry Co. Ltdreceives EXCiPACT certificate

EXCiPACT is pleased to announce that Nanjing Duoyuan Biochemistry Co. Ltd   has recently been awarded an EXCiPACT Certificate from SGS, one of EXCiPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Nanjing Duoyuan Biochemistry Co. Ltd site in Nanjing City, Jiangsu Province in PR China, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing of pharmaceutical grade Lanolin.

Read more

26 July 2016 – BCN Trasvases S.L. receives EXCiPACT certificate

EXCiPACT is pleased to announce that BCN Trasvases, S.L.  has recently been awarded an EXCiPACT Certificate from AENOR, one of EXCiPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that BCN Trasvases, S.L. site in Santa Perpetua de Mogoda (Barcelona), Spain, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers the packaging of calcium carbonate to be used as pharmaceutical excipient.

Read more

05 July 2016 – EXCiPACT certification scheme: triennial reregistration & recertification process off to a successful start

The Board of EXCiPACT asbl is pleased to announce that, as required by the rules of the independent EXCiPACT Certification Scheme for manufacturers and distributors of pharmaceutical grade excipients operational since 2013, the triennial reregistration of the Scheme’s Certifying Bodies, Auditors and the recertification of Certificate Holders, has successfully begun.

Read more

24 May 2016 – Ba’Emek Advanced Technologies Ltd receives EXCiPACT certificate

EXCiPACT asbl is delighted to announce that Ba’Emek Advanced Technologies Ltd has recently been awarded an EXCiPACT Certificate from AJA Europe, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Ba’Emek Advanced Technologies Ltd site in Afula, Israel, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers Pharma Grade Lactose Production and Storage in the pharmaceutical industry.

Read more

18 May 2016 – Colorcon Asia Private Limited receives EXCiPACT certificate

EXCiPACT is pleased to announce that Colorcon Asia Private Limited has recently been awarded an EXCiPACT Certificate from SGS Belgium, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Colorcon Asia Private Limited site in Goa, India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.  Its scope covers the manufacture and supply of pharmaceutical excipients of formulated powder (dry dispersion) comprising polymers, plasticizers, pigments and color and formulated blends of pigments and iron oxide.

Read more

20 April 2016 – Carbagas AG receives EXCiPACT certification

EXCiPACT is pleased to announce that Carbagas AG has recently been awarded an EXCiPACT Certificate from AJA Registrars Germany, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Carbagas AG site in Utzenstorf (Switzerland) manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope includes the design, production and storage of excipients  of pharmaceutical grade cryogenic liquefied gases (nitrogen, oxygen, argon).

Read more

19 April 2016 – Croda Singapore receives EXCiPACT certification

EXCiPACT is pleased to announce that Croda Singapore has recently been awarded an EXCiPACT Certificate from SGS Belgium, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Croda site in Singapore manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope includes the design, production and storage of excipients like Polysorbates, Sorbitan esters, medium chain triglycerides, mono and diglycerides, Propylene Glycol, Dicaprylate/ Dicaprate, Cetyl Palmitate, Diethylene Glycol Palmitostearate, Macrogol Stearate, Macrogol Stearyl Ether, Macrogol Glycerol Cocoates/Caprylocaprate.

Read more

8 March 2016 – ROQUETTE FRERES receives EXCiPACT certification

EXCiPACT asbl is pleased to announce that ROQUETTE FRERES has recently been awarded an EXCiPACT Certificate from SGS France, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the ROQUETTE FRERES site at Lestrem, France, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope includes the design, production and storage of excipients made from amylaceous substances such as certain starches and glucoses; sorbitol, maltitol, mannitol and xylitol powders, and maltitol solutions. This is the fifth site in France to receive EXCiPACT Certification since 2013 and is the 29th site to be certified globally to date. The other sites are in Canada, China, Belgium, Germany, India, The Netherlands, Saudi Arabia, Spain, USA and the UK.

Read more

12 January 2016 – Ashland U.S. Site receives EXCiPACT GMP certification

EXCiPACT asbl is delighted to announce that Ashland Specialty Ingredients ISP Chemicals LLC has recently been awarded an EXCiPACT Certificate from SGS ICS France, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Ashland Specialty Ingredients ISP Chemicals site in Calvert City, Kentucky manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. This is the first site in the U.S. to receive EXCiPACT Certification. Its scope covers the manufacturing, testing and packaging of PVP and PVPP used as pharmaceutical excipients. For full details of all 26 sites certified to date in Canada, China, Belgium, France, Germany, The Netherlands, Saudi Arabia, Spain, UK and USA, see http://www.excipact.org/certification/certificates

Read more

9 December 2015 – NOVACARB France receives EXCiPACT certification

EXCiPACT asbl is pleased to announce that Novacarb, France has recently been awarded an EXCiPACT™ Certificate from SGS ICS France, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Novacarb site at Laneuveville-devant-Nancy, France, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. This is the fourth site in France to receive EXCiPACT Certification since 2013 and is the 25th site to be certified globally to date. The others sites are in Canada, China, Belgium, Germany, The Netherlands, Saudi Arabia, Spain and the UK – see http://www.excipact.org/certification/certificates

Read more

28 October 2015 – CRODA CHOCQUES SAS France receives EXCiPACT certification

EXCiPACT asbl is pleased to announce that Croda Chocques SAS, France has recently been awarded an EXCiPACT Certificate from SGS ICS France, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Croda Chocques SAS site in France manufactures pharmaceutical excipients according to the EXCiPACT™ Good Manufacturing Practice (GMP) Certification Standard. This is the third Croda site in Europe to receive EXCiPACT Certification since 2014 and is the 24th site to be certified globally to date.

Read more

20 October 2015 – BOAI NKY PHARMACEUTICALS – First Chinese company to receive EXCiPACT certification

EXCiPACT asbl is delighted to announce that the first EXCiPACT Certificate in China has just been awarded to Boai NKY Pharmaceuticals Limited by Bureau Veritas Hong Kong, the latest addition to EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that Boai NKY Pharmaceuticals Limited’s site in Jiaozuo, Henan Province, China manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.

Read more

16 September 2015 – Bureau Veritas China becomes EXCiPACT Certifying Body

EXCiPACT asbl is pleased to announce the completion of an agreement with Bureau Veritas Certification Hong Kong Ltd, an internationally-recognised Certifying Body, for the certification of the manufacture and distribution of pharmaceutical excipients according to the EXCiPACT™ Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) Certification Standards.

Read more

1 July 2015 – Vikram Thermo (India) Limited receives EXCiPACT certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that Vikram Thermo (India) Limited has recently been awarded an EXCiPACT™ Certificate from SGS France, one of EXCIPACT’s internationally-recognised Certification Bodies. The Certificate demonstrates that the Vikram Thermo (India) Limited’s site in Gujarat, India, manufactures pharmaceutical excipients according to the EXCiPACTTM Good Manufacturing Practice (GMP) Certification Standard.

Read more

30 June 2015 – Ideal Cures Pvt. Ltd.’s third Indian site receives EXCiPACT certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that Ideal Cures Pvt. Ltd. of India has recently been awarded a third EXCiPACT™ Certificate from SGS France, one of EXCIPACT’s internationally-recognised Certification Bodies. The Certificate demonstrates that the Ideal Cures site at VasaiThane in India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.

Read more

17 June 2015 – Grace GmbH receives EXCiPACT certification as pharmaceutical excipient suppliers

EXCiPACT asbl is delighted to announce that Grace GmbH & Co. KG has recently been awarded an EXCiPACT™ Certificate from DGS GmbH, one of EXCIPACT’s internationally-recognised Certification Bodies. The Certificate demonstrates that the Grace site at Worms, Germany manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practices (GMP) Certification Standards.

Read more

3 February 2015 – EXCiPACT and NSF/IPEC/ANSI 363-2014 US national standard for pharmaceutical excipients

In order to further extend the scope of the EXCiPACT Certification Scheme to pharmaceutical excipient suppliers without ISO 9001 Certification, EXCiPACT asbl is pleased to announce that the new US National Standard, NSF/IPEC/ANSI 363-2014, can be used instead of the EXCiPACT GMP/GDP Standards for EXCiPACT™ Certification Audits.

Read more

8 April 2014 – EXCiPACT signs agreement with AJA Registrars Germany GmbH to undertake certified audits of pharmaceutical excipient suppliers

EXCiPACT asbl, a not-for-profit association, is pleased to announce that it has completed an Agreement with AJA Registrars Germany GmbH, an internationally-recognised Certifying Body, for the certification of the manufacture and distribution of pharmaceutical excipients according to the EXCiPACT™Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) Certification Standards.

Read more

19 February 2014 – Saudi Kayan received EXCiPACT certificate as pharmaceutical excipient supplier

EXCiPACT is delighted to announce that Saudi Kayan Petrochemical Company, of Jubail Industrial City, Saudi Arabia has received an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies. Saudi Kayan Petrochemical Company is an affiliate of Saudi Basic Industries Corporation (SABIC).

18 February 2014 – Sonneborn received EXCiPACT certificates as pharmaceutical excipient supplier

EXCiPACT is delighted to announce that SONNEBORN REFINED PRODUCTS of  Amsterdam, The Netherlands,  has received an EXCiPACT Certificate from SGS, one of EXCIPACT’s yinternationally-recognised Certification Bodies. Sonneborn Refined Products B.V.,  the European arm of US based Sonneborn LLC and global leader in specialty hydrocarbons.